Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Yuemiao Zhang"'
Publikováno v:
Renal Failure, Vol 46, Iss 1 (2024)
Hypertensive nephropathy continues to be a major cause of end-stage renal disease and poses a significant global health burden. Despite the staggering development of research in hypertensive nephropathy, scientists and clinicians can only seek out us
Externí odkaz:
https://doaj.org/article/6749170869f5475a82ef98996ed5d275
Autor:
Jingyi Li, Yaping Dong, Feifei Chen, Hongyu Yang, Pei Chen, Hongyu Li, Sufang Shi, Xujie Zhou, Li Zhu, Yuemiao Zhang, Lijun Liu, Xinfang Xie, Feng Yu, Jing Jin, Jicheng Lv, Hong Zhang
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionActivation of complement through the alternative pathway (AP) has a key role in the pathogenesis of IgA nephropathy (IgAN). We previously showed, by intraperitoneal injection of Lactobacillus casei cell wall extract (LCWE), C57BL/6 mice d
Externí odkaz:
https://doaj.org/article/bd48204f44c647858dee1285c396492a
Autor:
Yuemiao Zhang, Meng-Ting Luo, Qingqin Wu, Yun-Xia Wang, Xupu Ma, Guanghong Yan, Si-Hang Zhang, Yanli Chen, Na Wan, Liang Zhang, Dingyun You, Jia Wei, Zijie Zhang, Tai-Cheng Zhou, Precise-CoVaccine study group
Publikováno v:
Cell Discovery, Vol 9, Iss 1, Pp 1-4 (2023)
Externí odkaz:
https://doaj.org/article/abf2ef944cbc45c8abd14ec51eba1ba1
Autor:
Yuemiao Zhang, Xupu Ma, Guanghong Yan, Ying Wu, Yanli Chen, Zumi Zhou, Na Wan, Wei Su, Feng-Wei Liu, Mu-Xian Dai, Mei Yang, Chunmei Li, Xuanjing Yu, Liang Zhang, Zhongfang Wang, Tai-Cheng Zhou, Dingyun You, Jia Wei, Zijie Zhang
Publikováno v:
EClinicalMedicine, Vol 54, Iss , Pp 101680- (2022)
Summary: Background: More effective vaccine candidates against variants of concern as a booster dose are needed in people primed with two-dose inactivated COVID-19 vaccines. Methods: This randomised, double-blinded, investigator-initiated phase 2 tri
Externí odkaz:
https://doaj.org/article/1bc11f5adaf5496ba98f5e4bae7278bb
Autor:
Jie Zheng, Yuemiao Zhang, Huiling Zhao, Yi Liu, Denis Baird, Mohd Anisul Karim, Maya Ghoussaini, Jeremy Schwartzentruber, Ian Dunham, Benjamin Elsworth, Katherine Roberts, Hannah Compton, Felix Miller-Molloy, Xingzi Liu, Lin Wang, Hong Zhang, George Davey Smith, Tom R. Gaunt
Publikováno v:
EBioMedicine, Vol 81, Iss , Pp 104112- (2022)
Summary: Background: Recent omic studies prioritised several drug targets associated with coronavirus disease 2019 (COVID-19) severity. However, little evidence was provided to systematically estimate the effect of drug targets on COVID-19 severity i
Externí odkaz:
https://doaj.org/article/2b32a617988448219deabcd73b4ed55d
Autor:
Yuemiao Zhang, Ling Guo, Zi Wang, Jinwei Wang, Lee Er, Sean J. Barbour, Hernan Trimarchi, Jicheng Lv, Hong Zhang
Publikováno v:
Kidney International Reports, Vol 5, Iss 10, Pp 1753-1763 (2020)
Introduction: Two prediction models for IgA nephropathy (IgAN) using clinical variables and the Oxford MEST scores were developed and validated in 2 multiethnic cohorts. Additional external validation is required. Methods: Biopsy-proven Chinese and A
Externí odkaz:
https://doaj.org/article/4d99fbe1330e455da1deb84d5c512258
Publikováno v:
Glomerular Diseases (2021)
Externí odkaz:
https://doaj.org/article/f14bc3a72e664a70a0925fe4691b07f5
Autor:
Zhao Zhang, Guorong Zhang, Meng Guo, Wanyin Tao, Xingzi Liu, Haiming Wei, Tengchuan Jin, Yuemiao Zhang, Shu Zhu
Publikováno v:
Pathogens, Vol 10, Iss 7, p 881 (2021)
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global concern. Immunoglobin A (IgA) contributes to virus neutralization at the early stage of infection. Longitudinal studies are needed to assess whether SARS
Externí odkaz:
https://doaj.org/article/bd677f9b1bf54fe3a4379549e0e489dd
Autor:
Yuemiao Zhang, Jicheng Lv
Publikováno v:
Evidence‐Based Nephrology. :214-234
Publikováno v:
Pediatric Nephrology.